April 4, 2022
The University of Cincinnati, UC Health, Cincinnati Children’s and Kroger are partnering to help make health care more accessible to consumers in a first-of-its kind research study designed to improve health outcomes through retail-based dietary interventions.
January 25, 2022
The University of Cincinnati's Dr. Timothy Phoenix has received three separate grants from philanthropic organizations and the National Institutes of Health to learn more about the genetic workings of pediatric diffuse midline gliomas, a deadly brain tumor.
January 10, 2022
UC's Dr. Nalinikanth Kotagiri was featured in a Discover Magazine article focused on the use of bacteria to fight diseases including cancer.
November 19, 2021
University of Cincinnati College of Pharmacy researchers have engineered a probiotic bacteria designed to break down cancer cell walls to allow therapies easier access to shrink tumors.
November 22, 2021
University of Cincinnati researchers from the College of Pharmacy were featured in a Journal-News article detailing the development of a new probiotic bacteria designed to break down cancer cell walls.
February 2, 2022
Due to the predicted winter storm, Hoxworth Blood Center will close all Neighborhood Donor Centers and Blood Drives on Thursday, February 3.
March 14, 2022
55KRC featured the University of Cincinnati's Dr. Timothy Phoenix on the Simply Medicine program, discussing his research into treatments for diffuse midline glioma, a deadly pediatric brain tumor.
February 4, 2022
Medical Xpress highlighted the work of the University of Cincinnati's Timothy Phoenix and his colleagues who have identified the role of a key gene linked to pediatric diffuse midline gliomas, a deadly brain tumor.
July 19, 2022
Sushruth Muthuluru, a graduate of duPont Manual High School in Louisville, Kentucky, is an incoming Cincinnatus Presidential Scholar who has already conducted four years of medical research.
July 11, 2022
Over decades of ups and downs, the hard work of University of Cincinnati alumnus John Drach paid off when the FDA approved a new drug he helped develop to treat cytomegalovirus.